News
- October 13, 2020
- Asahi Kasei Pharma to solicit proposals for drug discovery research
- June 2, 2020
- Asahi Kasei Pharma obtains Chinese approval for Flivas™ (naftopidil) dysuria treatment
- March 19, 2020
- Asahi Kasei Pharma concludes license agreement with SBI Biotech for SBI-3150
- January 9, 2020
- Denial of motion for preliminary injunction requesting continuous supply of XIAFLEX® injection